The effect of membrane cholesterol content on ion transport processes in plasma membranes

Cardiovascular Research

Volumn 33, Issue 2, 1997, Pages 272-283

  Lars Bastiaanse, E M ^a   Höld, Karin M ^a   Van Der Laarse, Arnoud ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cholesterol; ion channels; ion transport; sarcolemma

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHOLESTEROL;

ANIMAL CELL; ANIMAL TISSUE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; ION TRANSPORT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CHOLESTEROL; HUMANS; ION TRANSPORT; MYOCARDIUM;

EID: 0031036109     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00193-9     Document Type: Review

References (82)

1. Oliver MF. Lipids and coronary disease - resolved and unresolved problems. Br Med Bull 1990;46:865-872.
2. Steinberg D. The cholesterol controversy is over. Why did it take so long? Circulation 1989;80:1070-1078.
3. Bloch K. Cholesterol: evolution of structure and function. In: Vance DE, Vance JE, eds. Biochemistry of Lipids, Lipoproteins and Membranes, vol 20, series New Comprehensive Biochemistry (Neuberger A, Van Deenen LLM, general eds.). Amsterdam: Elsevier Science Publishers, 1991:363-381.
4. Fielding CJ. Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration. FASEB J 1992;6:3162-3168.
5. Yeagle PL. Cholesterol and the cell membrane. Biochim Biophys Acta 1985;822:267-287.
6. Gennis RB. Biomembranes: molecular structure and function. Cantor CR, ed. New York: Springer-Verlag, 1989.
7. Van der Laarse A. Cholesterol and myocardial membrane function. Basic Res Cardiol 1987;82(suppl 1):137-145.
8. Myant NB. The biology of cholesterol and related steroids. London: William Heinemann Medical Books, 1981.
9. Davis RA, Sinensky M, Junker LH. Regulation of cholesterol synthesis and the potential for its pharmacological manipulation. Pharmacol Ther 1989;43:221-236.
10. Schroeder F, Jefferson JR, Kier AB, et al. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc Soc Exp Biol Med 1991;196:235-252.
11. Dawidowicz EA. Dynamics of membrane lipid metabolism and turnover. Annu Rev Biochem 1987;56:43-61.
12. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 1972;175:720-731.
13. Van der Meer BW. Physical aspects of membrane fluidity. In: Shinitzky M, ed. Physiology of Membrane Fluidity, vol 1. Boca Raton, FL: CRC Press, 1984:53-71.
14. Van der Meer BW. Biomembrane structure and dynamics viewed by fluorescence. In: Hilderson et al., eds. Subcellular Biochemistry, vol 13. London: Plenum Press, 1988:1-53.
15. Presti FT. The role of cholesterol in regulating membrane fluidity. In: Gordon LM, ed. Membrane Fluidity in Biology, vol 4. New York: Academic Press, 1985:97-146.
16. Kirkwood A, Pritchard JR, Schwarz SM, Medow MS, Stemerman MB. Effect of low-density lipoprotein on endothelial cell membrane fluidity and mononuclear cell attachment. Am J Physiol 1991;260:C43-C49.
17. Schwarz SM, Bostwick HE, Danziger MD, Newman LJ, Medow MS. Ontogeny of basolateral membrane lipid composition and fluidity in small intestine. Am J Physiol 1989;257:G138-G144.
18. Demel RA, De Kruyff B. The function of sterols in membranes. Biochim Biophys Acta 1976;457:109-132.
19. Bastiaanse EML, Atsma DE, Van der Valk LJM, Van der Laarse A. Metabolic inhibition of cardiomyocytes causes an increase in sarcolemmal fluidity which may be due to loss of cellular cholesterol. Arch Biochem Biophys 1995;319:350-354.
20. Shinitzky M. Membrane fluidity and cellular functions. In: Shinitzky M, ed. Physiology of Membrane Fluidity, vol 1. Boca Raton, FL: CRC Press, 1984:1-51.
21. Gordon LM, Mobley PW. Membrane lipids, membrane fluidity, and enzyme activity. In: Gordon LM, ed. Membrane Fluidity in Biology, vol 4. New York: Academic Press, 1985:1-49.
22. Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem 1987;56:395-433.
23. Dupuis BA, Adamantidis MM. Cardiac calcium channels: general properties and influence of calcium antagonists. In: Hearse DJ, Puech P, eds. Myocardial Protection and Calcium Antagonists. Amsterdam: Excerpta Medica, 1987:1-21.
24. Langer GA. Calcium and the heart: exchange at the tissue, cell, and organelle levels. FASEB J 1992;6:893-902.
25. Broderick R, Bialecki R, Tulenko TN. Cholesterol-induced changes in rabbit arterial smooth muscle sensitivity to adrenergic stimulation. Am J Physiol 1989;257:H170-H178.
26. Bialecki RA, Tulenko TN. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am J Physiol 1989;257:C306-C314.
27. Tulenko TN, Bialecki R, Gleason M, D'Angelo G. Ion channels, membrane lipids and cholesterol: a role for membrane lipid domains in arterial function. In: Colatsky T, ed. Potassium Channels: Basic Function and Therapeutic Aspects. New York: Alan R Liss, 1990:187-203.
28. Gleason MM, Medow MS, Tulenko TN. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ Res 1991;69:216-227.
29. Bialecki RA, Tulenko TN, Colucci WS. Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells. J Clin Invest 1992;88:1894-1900.
30. Strickberger SA, Russek LN, Phair RD. Evidence for increased aortic plasma membrane calcium transport caused by experimental atherosclerosis in rabbits. Circ Res 1988;62:75-80.
31. Zhou Q, Jimi S, Smith TL, Kummerow FA. The effect of cholesterol on the accumulation of intracellular calcium. Biochim Biophys Acta 1991;1085:1-6.
32. Bastiaanse EML, Atsma DE, Kuijpers MMC, Van der Laarse A. The effect of sarcolemmal cholesterol content on intracellular calcium ion concentration in cultured cardiomyocytes. Arch Biochem Biophys 1994;313:58-63.
33. 2+ and phospholipase A activity independent of changes in inositol triphosphates and agonist/receptor binding. Biochem J 1990;265:747-754.
34. 2+-mobilization in monocytic U937 cells. Biochim Biophys Acta 1991;1074:125-129.
35. Locher R, Neyses L, Stimpel M, Küffer B, Vetter W. The cholesterol content of the human erythrocyte influences calcium influx through the channel. Biochem Biophys Res Commun 1984;124:822-828.
36. Renaud JF, Scanu AM, Kazazoglou T, Lombet A, Romey G, Lazdunski M. Normal serum and lipoprotein-deficient serum give different expressions of excitability, corresponding to different stages of differentiation, in chicken cardiac cells in culture. Proc Natl Acad Sci USA 1982;79:7768-7772.
37. 2+)-ATPase from cardiac muscle. Biochim Biophys Acta 1984;773:231-236.
38. Ortega A, Mas-Oliva J. Direct regulatory effect of cholesterol on the calmodulin stimulated calcium pump of cardiac sarcolemma. Biochem Biophys Res Commun 1986;139:868-874.
39. 2+)-ATPase from cardiac muscle sarcolemma. Biochem Int 1990;21:233-241.
40. 2+-ATPaSe activity of sarcoplasmic reticulum by membrane cholesterol: the effect of enzyme coupling. Biochim Biophys Acta 1981;641:265-269.
41. Warren GB, Houslay MD, Metcalfe JC, Birdsall NJM. Cholesterol is excluded from the phospholipid annulus surrounding an active calcium transport protein. Nature 1975;255:684-687.
42. Johansson A, Keightley CA, Smith GA, Metcalfe JC. Cholesterol in sarcoplasmic reticulum and the physiological significance of membrane fluidity. Biochem J 1981;196:505-511.
43. 2+)-ATPase. Biochim Biophys Acta 1982;693:398-406.
44. Sheu SS, Blaustein MP. Sodium/calcium exchange and control of cell calcium and contractility in cardiac and vascular smooth muscles. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System, 2nd edn. New York: Raven Press, 1992:903-943.
45. Kutryk MJB, Pierce GN. Stimulation of sodium-calcium exchange by cholesterol incorporation into isolated cardiac sarcolemmal vesicles. J Biol Chem 1988;263:13167-13172.
46. Kutryk MJB, Maddaford TG, Ramjiawan B, Pierce GN. Oxidation of membrane cholesterol alters active and passive transsarcolemmal calcium movement. Circ Res 1991;68:18-26.
47. + pump in erythrocytes. Biochim Biophys Acta 1981;647:249-258.
48. Claret M, Garay R, Giraud F. The effect of membrane cholesterol on the sodium pump in red blood cells. J Physiol 1978;274:247-263.
49. +)-ATPase ATP hydrolyzing activity in the human erythrocyte. Biochim Biophys Acta 1983;727:39-44.
50. Kroes J, Ostwald R. Erythrocyte membranes - effect of increased cholesterol content on permeability. Biochim Biophys Acta 1971;249:647-650.
51. Field FJ, Albright E, Mathur SN. Effect of dietary cholesterol on biliary cholesterol content and bile flow in the hypothyroid rat. Gastroenterology 1985;91:297-304.
52. +)-stimulated adenosine triphosphatase. J Biol Chem 1974;249:1071-1080.
53. +)-ATPase ATP hydrolyzing activity in bovine kidney. Biochemistry 1988;27:6449-6452.
54. + channels and membrane fluidity in vascular smooth muscle cells. Pflügers Arch 1989;415:262-268.
55. + channels in smooth muscle cells from human aorta. Proc Roy Soc London 1989;237:259-266.
56. Fishman GI. Connexin and the heart. Trends Cardiovasc Med 1992;2:50-55.
57. Page E. Cardiac gap junctions. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System, 2nd edn. New York: Raven Press, 1992:1003-1047.
58. Malewicz B, Kumar VV, Johnson RG, Baumann WJ. Lipids in gap junction assembly and function. Lipids 1990;25:419-427.
59. Meyer R, Malewicz B, Baumann WJ, Johnson RG. Increased gap junction assembly between cultured cells upon cholesterol supplementation. J Cell Sci 1990;96:231-238.
60. Meyer RA, Lampe PD, Malewicz B, Baumann WJ, Johnson RG. Enhanced gap junction formation with LDL and apolipoprotein B. Exp Cell Res 1991;196:72-81.
61. Zwijsen RML, Oudenhoven IKJ, De Haan LHJ. Effects of cholesterol and oxysterols on gap junctional communication between human smooth muscle cells. Eur J Pharmacol 1991;228:115-120.
62. Bastiaanse EML, Jongsma HJ, Van der Laarse A, Takens-Kwak BR. Heptanol-induced decrease in cardiac gap junctional conductance is mediated by a decrease in the fluidity of membranous cholesterol-rich domains. J Membr Biol 1993;136:135-145.
63. Barnett JV, Haigh LS, Marsh JD, Galper JB. Effects of low density lipoproteins and mevinolin on sympathetic responsiveness in cultured chick atrial cells. J Biol Chem 1989;264:10779-10786.
64. Haigh LS, Leatherman GF, O'Hara DS, Smith TW, Galper JB. Effect of low density lipoproteins and mevinolin on cholesterol content and muscarinic cholinergic responsiveness in cultured chick atrial cells. J Biol Chem 1988;263:15608-15618.
65. Dalziel AW, Rollins ES, McNamee MG. The effect of cholesterol on agonist-induced flux in reconstituted acetylcholine receptor vesicles. FEBS Lett 1980;122:193-196.
66. Criado M, Eibl H, Barrantes FJ. Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry 1982;21:3622-3629.
67. Pedersen PL, Carafoli E. Ion motive ATPases. I. Ubiquity, properties, and significance to cell function. Trends Biochem Sci 1987;12:146-150.
68. Stein WD. Transport and Diffusion across Cell Membranes. New York: Academic Press, 1986.
69. Trudell JR. Role of membrane fluidity in anesthetic action. In: Aloia RC, Curtain CC, Gordon LM, eds. Drug and Anesthetic Effects on Membrane Structure and Function. New York: Wiley-Liss, 1991:1-14.
70. Trudell JR. Unitary theory of anesthesia based on lateral phase separations in nerve membranes. Anesthesiology 1977;46:5-10.
71. Curtain CC, Looney FD, Smelstorium JA. Lipid domain formation and ligand-induced lymphocyte membrane changes. Biochim Biophys Acta 1980;596:43-56.
72. 5 vascular smooth muscle cells. Eur J Pharmacol 1991;206:279-284.
73. 2+ channel blockers. Atherosclerosis 1991;88:109-132.
74. Waters D, Lesperance J, Francetich M, et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990;82:1940-1953.
75. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990;11(suppl E):3-19.
76. Venter H, Genade S, Mouton R, Huisamen B, Harper IS, Lochner A. Myocardial membrane cholesterol: effects of ischemia. J Mol Cell Cardiol 1991;23:1271-1286.
77. Altona JC, Van der Laarse A. Anoxia-induced changes in composition and permeability of sarcolemmal membranes in rat heart cell cultures. Cardiovasc Res 1982;16:138-143.
78. 2+ in the function and dysfunction of heart mitochondria. In: Langer G.A, ed. Calcium and the Heart. New York: Raven Press, 1990:167-198.
79. 2+ activated hydrophilic channel of the mitochondrial inner membrane by nucleotides. J Membr Biol 1980;54:231-236.
80. 2+ overload. Eur J Biochem 1988;178:489-501.
81. Bastiaanse EML, Van der Valk-Kokshoorn LJM, Egas-Kenniphaas JM, Atsma DE, Van der Laarse A. The effect of sarcolemmal cholesterol content on the tolerance to anoxia in cardiomyocyte cultures. J Mol Cell Cardiol 1994;26:639-648.
82. Rouslin W, MacGee J, Wessalam A, Adams JR, Gupte S. Canine myocardial ischemia: increased mitochondrial cholesterol, a marker of mitochondrial membrane injury. J Mol Cell Cardiol 1980;12:1475-1482.